CD22 CAR T-cell therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD22 CAR T-cell therapy, covering 2026-04-24 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia [Phase 2]